AAAAAA

   
Results: 1-10 |
Results: 10
Kinetic and titration methods for determination of active site contents ofenzyme and catalytic antibody preparations
Authors: Brocklehurst, K Resmini, M Topham, CM
Citation: K. Brocklehurst et al., Kinetic and titration methods for determination of active site contents ofenzyme and catalytic antibody preparations, METHODS, 24(2), 2001, pp. 153-167
On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family
Authors: Topham, CM Mouledous, L Meunier, JC
Citation: Cm. Topham et al., On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family, PROTEIN ENG, 13(7), 2000, pp. 477-490
A general kinetic approach to investigation of active-site availability inmacromolecular catalysts
Authors: Resmini, M Gul, S Carter, S Sonkaria, S Topham, CM Gallacher, G Brocklehurst, K
Citation: M. Resmini et al., A general kinetic approach to investigation of active-site availability inmacromolecular catalysts, BIOCHEM J, 346, 2000, pp. 117-125
The nociceptin (ORL1) receptor: molecular cloning and functional architecture
Authors: Meunier, JC Mouledous, L Topham, CM
Citation: Jc. Meunier et al., The nociceptin (ORL1) receptor: molecular cloning and functional architecture, PEPTIDES, 21(7), 2000, pp. 893-900
Functional inactivation of the nociceptin receptor by alanine substitutionof glutamine 286 at the c terminus of transmembrane segment VI: Evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain
Authors: Mouledous, L Topham, CM Moisand, C Mollereau, C Meunier, JC
Citation: L. Mouledous et al., Functional inactivation of the nociceptin receptor by alanine substitutionof glutamine 286 at the c terminus of transmembrane segment VI: Evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain, MOLEC PHARM, 57(3), 2000, pp. 495-502
The kinetic basis of a general method for the investigation of active sitecontent of enzymes and catalytic antibodies: First-order behaviour under single-turnover and cycling conditions
Authors: Topham, CM Gul, S Resmini, M Sonkaria, S Gallacher, G Brocklehurst, K
Citation: Cm. Topham et al., The kinetic basis of a general method for the investigation of active sitecontent of enzymes and catalytic antibodies: First-order behaviour under single-turnover and cycling conditions, J THEOR BIO, 204(2), 2000, pp. 239-256
Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa(10),Tyr(14)]nociceptin
Authors: Mouledous, L Topham, CM Mazarguil, H Meunier, JC
Citation: L. Mouledous et al., Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa(10),Tyr(14)]nociceptin, J BIOL CHEM, 275(38), 2000, pp. 29268-29274
Molecular modelling of the ORL1 receptor and its complex with nociceptin (vol 11, pg 1163, 1998)
Authors: Topham, CM Mouledous, L Poda, G Maigret, B Meunier, JC
Citation: Cm. Topham et al., Molecular modelling of the ORL1 receptor and its complex with nociceptin (vol 11, pg 1163, 1998), PROTEIN ENG, 12(10), 1999, pp. 893-893
The influence of helix morphology on co-operative polyamide backbone conformational flexibility in peptide nucleic acid complexes
Authors: Topham, CM Smith, JC
Citation: Cm. Topham et Jc. Smith, The influence of helix morphology on co-operative polyamide backbone conformational flexibility in peptide nucleic acid complexes, J MOL BIOL, 292(5), 1999, pp. 1017-1038
Molecular modelling of the ORL1 receptor and its complex with nociceptin
Authors: Topham, CM Mouledous, L Poda, G Maigret, B Meunier, JC
Citation: Cm. Topham et al., Molecular modelling of the ORL1 receptor and its complex with nociceptin, PROTEIN ENG, 11(12), 1998, pp. 1163-1179
Risultati: 1-10 |